Showing 2 results for Renal Failure.
G Hashemi, H Autookesh,
Volume 11, Issue 1 (5-1997)
Abstract
We have used recombinant human erythropoietin (r-HuEPO) in children with
chronic renal failure. There was significant improvement in anemia and wellbeing,
along with regression of left ventricular mass and no change in the rate of
decline of renal function. It is safe and effective in the pre-dialysis as well as the
hemodialysis period. Considering the benefits of r-HuEPO, transplantation in
children can be postponed to a later time, when sufficient growth and development
have occurred, leading to better results of transplantation
Z Ghoreshi, Sk Ahaley, I Rasooli,
Volume 14, Issue 4 (2-2001)
Abstract
Hemodialysis is being implicated in the development of metabolic disturbances,
as complications have been observed and the role of trace metals in their
development has been questioned. In 78 renal failure patients who underwent
hemodialysis, serum levels of zinc and copper were determined before and after
first hemodialysis. Acute and chronic renal failure patients were found to have
lower serum zinc levels before hemodialysis and higher levels after hemodialysis,
while serum copper levels were found to be higher before hemodialysis and
to increase further after hemodialysis. Disturbances in acid-base balance lead to
acidosis which can alter the binding, transport and excretion of these elements.
Dialysis fluid containing salts of trace elements may have also contributed to this
alteration of trace element levels.
